Here the authors show that deficiency of the Rap1 GTPase-activating protein Sipa1 in the tumor microenvironment releases an immune response that eradicates CML-initiating cells via interplay between stromal and T cells. The gene discussed is SIPA1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.